European Pharmaceutical Manufacturer: Catherine Wilkes on Achieving HPAPI Manufacturing Success
With the use of highly potent active pharmaceutical ingredients (HPAPIs) on the rise in the pharmaceutical industry, Catherine Wilkes, Executive Director of Environmental, Health and Safety at Quotient Sciences has been featured in European Pharmaceutical Manufacturer.
In this article, Catherine explores how containment protocols shift when dealing with HPAPIs to meet the required safety standards. The ability of HPAPIs to target and prompt a pharmacological response (at low concentrations) makes them promising drug candidates, especially those for oncology and orphan rare disease indications.
Read more of Catherine's recent contribution on the European Pharmaceutical Manufacturer website by following the link below.
About Catherine Wilkes, Executive Director, Environmental, Health & Safety (EHS)
Catherine Wilkes has over 25 years of experience working in the pharmaceutical industry and in particular the early drug development space. She has over 20 years of experience working in an EHS role. She has first-hand experience in tailoring safety programs in a fast-paced commercial environment with focused expertise in advising on the management of risks associated with handling hazardous substances, including highly-potent active pharmaceutical ingredients (API), ionising radiation and biological substances. Catherine is a qualified safety professional and is a chartered member of the Institute of Occupational Safety & Health (IOSH) and a fellow of the International Institute of Risk & Safety Management (IIRSM).